Acharya, Daniel A, Gyadangi B, Ramsamy S. Isolation, characterization of a potential degradation product of aspirin and an HPLC method for quantitative estimation of its impurities. J Chrom Sci, 2015; 53(9):1491-7. https://doi.org/10.1093/chromsci/bmv043 |
|
Barberi-Heyob M, Merlin JL, Pons L, Calco M, Weber B. A sensitive isocratic liquid chromatography assay for the determination of dipyridamole in plasma with electrochemical detection. J LiqChrom, 2006; 17:1837-48.ß https://doi.org/10.1080/10826079408013462 |
|
Bridle JH, Brimble MT. A stability indicating method for dipyridamole. Informa Heal Drug Dev Ind Pharm, 2008; 19:371-81. https://doi.org/10.3109/03639049309038773 |
|
Bult H, Fret HR, Jordaens FH, Herman AG. Dipyridamole potentiates platelet inhibition by nitric oxide. Thromb Haemost, 1991; 66(3):343-9. PMID: 1746006. https://doi.org/10.1055/s-0038-1646418 |
|
Center for Drug Evaluation and Research. Validation of chromatographic methods. Docket ID: FDA-2013-S-0610, 1994. Available via https://www.fda.gov/media/75643/download |
|
Fontani F, Finardi GP, Targa G, Besana GP, Ligorati M. Purity evaluation of dipyridamole by high-performance liquid chromatography. JChrom A, 1983; 280:181-7. https://doi.org/10.1016/S0021-9673(00)91557-7 |
|
Hassan H, Hammud, Fawzy A. El Yazbib, Mohamad E. Mahrous, Ghassan M. Sonji, Nada M. Sonji. Stability-indicating spectrofluorimetric and RP-HPLC methods for the determination of aspirin and dipyridamole in their combination. OpeSpect J, 2008; 2:19-28. https://doi.org/10.2174/1874383800802010019 |
|
ICH Q2 (R1). Validation of analytical procedures: text and methodology. International Conference on Harmonization, 2005. |
|
Rajput AP, Sonanis MC. Development and validation of a rapid RP-UPLC method for the determination of aspirin and dipyridamole in combined capsule formulation. Int J Pharm Pharma Sci, 2011; 3:156-60. |
|
Rao AS, Rao K, Dadichand AS, Punna Rao AML, Balaswami B. Development and validation of RP-HPLC method for assay of dipyridamole in formulations. J Pharm Sci Res, 2016; 8(5):256-9. |
|
USFDA. Analytical procedures and methods validation for drugs and biologics. Docket ID: FDA-2015-N-0007, 2015. Available via https:// www.fda.gov/media/87801/download |
|
Vaghela B, Rao SS, Reddy SP. Development and validation of a stability indicating RP-LC method for the estimation of process related impurities and degradation products of dipyridamole retard capsules. Int J Pharm Pharm Sci, 2012; 4:615-22. |
|
Yogesh D Bommegowda, Dinesh B Shenoy, Menaka T, Chethan BP, Nagaraja G, Fazil Baig, Sandeep K N, Venkanna Babu. Synthesis of novel pyrimido-[5, 4-d] pyrimidines by sequential nucleophillic substitution reaction. J Chem Pharm Res, 2012; 11:4888-93. |
|
Zhang J, Miller RB, Jacobus R. Development and validation of a stability-indicating HPLC method for the determination of degradation products in dipyridamole injection. Chromatographia, 1997; 44:247-52. https://doi.org/10.1007/BF02466389 |